Firefly Aerospace's successful Nasdaq debut, raising $868M and reaching a valuation close to $10B, reflects strong investor enthusiasm for its space technology.
Trump and Netanyahu clash over reports of starvation in Gaza, as the humanitarian crisis worsens and the US sends aid.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Firefly Aerospace's successful Nasdaq debut, raising $868M and reaching a valuation close to $10B, reflects strong investor enthusiasm for its space technology.
Trump and Netanyahu clash over reports of starvation in Gaza, as the humanitarian crisis worsens and the US sends aid.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.